Theriva Biologics, Inc. Accounts Receivable, Allowance for Credit Loss, Current
Theriva Biologics, Inc. (TOVX) had Accounts Receivable, Allowance for Credit Loss, Current of $682.00 thousand as of 2012-12-31, per its 10-K filed 2013-04-16.
Discontinued › Balance Sheet › Assets › Assets, Current › Accounts Receivable, after Allowance for Credit Loss, Current
us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent · last filed 2013-04-16
- 2012-12-31: Accounts Receivable, Allowance for Credit Loss, Current $682.00K.
- 2012-09-30: Accounts Receivable, Allowance for Credit Loss, Current -$560.00K.
- 2012-06-30: Accounts Receivable, Allowance for Credit Loss, Current -$454.00K.
- 2011-12-31: Accounts Receivable, Allowance for Credit Loss, Current $287.00K; Accounts Receivable, Allowance for Credit Loss, Current as first filed -$287.00K.
| Period end | Accounts Receivable, Allowance for Credit Loss, Current | Accounts Receivable, Allowance for Credit Loss, Current as first filed |
|---|---|---|
| 2012-12-31 | $682.00K 10-K · filed 2013-04-16 | |
| 2012-09-30 | -$560.00K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$454.00K 10-Q/A · filed 2012-09-11 | |
| 2011-12-31 | $287.00K 10-K · filed 2013-04-16 | -$287.00K 10-Q/A · filed 2012-09-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |